Watch Demo

The Czech Republic Antidiabetics Industry Outlook 2024 - 2028

See how the Czech Republic Antidiabetics performed compared to key markets.

Key Market Indicators

**Czech Insulin Imports Projected to Surge to $191 Million by 2028** **Prague** – The import value of insulin to the Czech Republic is projected to rise to approximately $191 million by 2028, up from around $168 million in 2023. This marks an average annual growth rate of 1.9%. Since 1998, the demand for insulin in the Czech Republic has shown a consistent increase, averaging a 2.6% year-on-year growth. **Czech Insulin Exports to Reach $78 Million by 2028** Czech insulin exports are also on the rise. The export value is expected to climb to about $78 million by 2028, up from nearly $66 million in 2023, with an average annual growth rate of 2.6%. Since 1998, the supply of insulin from the Czech Republic has increased at an average rate of 2.9% annually. In 2023, the Czech Republic ranked 10th in global insulin exports, with the United Kingdom leading at approximately $66 million. France, Italy, and China followed in second, third, and fourth place, respectively.

Marketing Banner

The Czech Republic Antidiabetics Market Data and Forecasts

How much will the Czech Republic Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Czech Republic
Forecast: Import of Insulin in Dosage Forms to Czech Republic
Forecast: Export of Insulin in Dosage Forms from Czech Republic
Forecast: Export of Insulin Not in Dosage Forms from Czech Republic
Forecast: Import of Insulin in Dosage Forms to Czech Republic
More in Antidiabetics Industry for 2028